News
Therapists are cautious about sharing personal information. When they fall ill or die unexpectedly, the shock can be ...
Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces that it will be attending, exhibiting, ...
Ozzy Osbourne died at 76, weeks after farewell concert with Black Sabbath, closing a legendary era in heavy metal. Newsweek's ...
GPs are set to play a key role in delivering care for people with mild and moderate ME/CFS under a new delivery plan.
Drs Kathryn J. Ruddy and Narjust Florez discuss fertility, pregnancy, sexual health, delays in diagnosis, and the financial ...
To address the gap in sepsis management bundle compliance at a community hospital in Cleveland, Ohio, the authors created an intervention targeting patients who presented with sepsis upon admission, ...
A new framework published in JAMA Internal Medicine offers a systematic approach to this challenge. Researchers described the ...
McArthur Davis was 18 when doctors told him to burn his clothes to cure what they thought was an infection. His vision was ...
England will have a single national formulary (SNF) for prescribing within the next two years, the NHS 10-year plan has set ...
Krystal Biotech Announces First Patient Dosed in Phase 1/2 Trial of KB801 for the Treatment of Neurotrophic Keratitis ...
According to the Chairman of the NMA Lagos State Branch, Babajide Saheed, the new salary plan disregards salary relativity between doctors and other health workers.
CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor Novo Nordisk, will still be covered under plans managed by CVS Caremark.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results